Table 3.

Resolution of treatment-related side effects on follow-up (n = 14)

typical side effects	CTC grade	end of treatment (N = 14)	6 weeks post completion of treatment, N = 14	4-5 months post completion of treatment, N = 14
mucositis	I	2 (14.3%)	5 (35.7%)	3 (21.4%)
	II	8 (57.1%%)	2 (14.3%)
	III	4 (28.6%)	0
dermatitis	I	2 (14.3%)	6 (42.9%)
	II	6 (42.9%)	0
	III	2 (14.3%)	0
acneiforme skin rash	I	5 (35.7%)	1 (7.1%)
	II	9 (64.3%)	0
	III	1 (7.1%)	0
dysphagia	I	5 (35.7%)	4 (28.6%)
	II	7 (50%)	9 (64.3%)	3 (21.4%)
	III	1 (7.1%)	1 (7.1%)	1 (7.1%)
xerostomia	I	8 (57.1%)	9 (64.3%)	10 (71.4%)
	II	5 (35.7%)	2 (14.3%)	1 (7.1%)